Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation

David Budd1 Bristol-Myers Squibb, Princeton, NJ, USACorrespondence[email protected]

Leah C Burns2 Bristol-Myers Squibb, Wallingford, CT, USA

Zhenchao Guo2 Bristol-Myers Squibb, Wallingford, CT, USA

Gilbert L’Italien2 Bristol-Myers Squibb, Wallingford, CT, USA;3 Yale University School of Medicine, New Haven, CT, USA

Pablo Lapuerta1 Bristol-Myers Squibb, Princeton, NJ, USA

Pages 189-195 | Published online: 07 Oct 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CummingsJLAlzheimer’s diseaseN Engl J Med20043511566715229308
PubMed Web of Science ®Google Scholar
FerriCPPrinceMBrayneCGlobal prevalence of dementia: a Delphi consensus studyLancet200536695032112211716360788
PubMed Web of Science ®Google Scholar
Alzheimer’s Association2010 Alzheimer’s disease facts and figuresAlzheimers Dement20106215819420298981
PubMed Web of Science ®Google Scholar
SadikKWilcockGThe increasing burden of Alzheimer diseaseAlzheimer Dis Assoc Disord200317Suppl 3S75S7914512820
PubMed Web of Science ®Google Scholar
MitchellAJMonge-ArgilésJASánchez-PayaJDo CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?Pract Neurol201010420220720647526
PubMedGoogle Scholar
SallowaySMintzerJWeinerMFCummingsJLDisease-modifying therapies in Alzheimer’s diseaseAlzheimer Dement2008426579
PubMed Web of Science ®Google Scholar
BatemannRJKlunkWEMeasuring target effect of proposed disease-modifying therapies in Alzheimer’s diseaseNeurotherapeutics20085338139018625449
PubMed Web of Science ®Google Scholar
SallowaySCorreiaSAlzheimer disease: time to improve its diagnosis and treatmentCleve Clin J Med2009761495719122111
PubMed Web of Science ®Google Scholar
LandauSMHarveyDMadisonCMComparing predictors of conversion and decline in mild cognitive impairmentNeurology201075323023820592257
PubMed Web of Science ®Google Scholar
AnderssonCBlennowKJohanssonS-EDifferential CSF biomarker levels in APOE-ε4-positive and -negative patients with memory impairmentDement Geriatr Cogn Disord2007232879517124416
PubMed Web of Science ®Google Scholar
MattsonNZetterbergHHanssonOCSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairmentJAMA2009302438539319622817
PubMed Web of Science ®Google Scholar
BlennowKZetterbergHCerebrospinal fluid biomarkers for Alzheimer’s diseaseJ Alzheimers Dis200918241341719661632
PubMed Web of Science ®Google Scholar
DuboisBFeldmanHHJacovaCResearch criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteriaLancet Neurol20076873474617616482
PubMed Web of Science ®Google Scholar
BriggsASculpherMAn introduction to Markov modelling for economic evaluationPharmacoeconomics199813439740910178664
PubMed Web of Science ®Google Scholar
StewartAPhillipsRDempseyGPharmacotherapy for people with Alzheimer’s disease: a Markov-cycle evaluation of five years’ therapy using donepezilInt J Geriatr Psychiatry19981374454539695032
PubMed Web of Science ®Google Scholar
JackCRLoweVJWeigandSDfor Alzheimer’s Disease Neuroimaging InitiativeSerial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s diseaseBrain2009132Pt 51355136519339253
PubMed Web of Science ®Google Scholar
HuxMJO’BrienBJIskedjianMGoereeRGagnonMGauthierSRelation between severity of Alzheimer’s disease and costs of caringCMAJ199815954574659757169
PubMed Web of Science ®Google Scholar
United States statistical abstract 2010 Available from: http://www.census.gov/compendia/statab/2010/2010edition.html. Accessed October 15, 2010.
Google Scholar
NeumannPJArakiSSArcelusAMeasuring Alzheimer’s disease progression with transition probabilities: estimates from CERADNeurology200157695796411571317
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date